Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.

@article{Poveda2007PrevalenceOE,
  title={Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.},
  author={Eva Poveda and C. Castro Garrido and Carmen de Mendoza and Ang{\'e}lica Corral and Julio Alberto Martinez Cobo and J. Gonz{\'a}lez-lahoz and Vicente Soriano},
  journal={The Journal of antimicrobial chemotherapy},
  year={2007},
  volume={60 6},
  pages={
          1409-10
        }
}
1. Colford JM, Mohle-Boetani J, Vosti KL. Group B streptococcal bacteremia in adults. Five years’ experience and a review of the literature. Medicine (Baltimore) 1995; 74: 176–90. 2. Huang PY, Lee MH, Yang CC et al. Group B streptococcal bacteremia in non-pregnant adults. J Microbiol Immunol Infect 2006; 39: 237–41. 3. Stylianopoulos A, Kelly N, Garland S. Is penicillin and/or erythromycin resistance present in clinical isolates of group B Streptococcus in our community? Aust N Z J Obstet… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-7 OF 7 REFERENCES

Development of a list of mutations associated with NNRTI resistance for use in clinical research

L Tambuyzer, J Vingerhoets, H Azijn
  • Abstract 67
  • 2007
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Impact of baseline NNRTI mutations on the virological response to TMC125 in the Phase III clinical trials DUET-1 and DUET-2

J Vingerhoets, A Buelens, M Peeters
  • Antivir Ther
  • 2007
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Update of the Drug Resistance Mutations in HIV-1.

  • Topics in HIV medicine : a publication of the International AIDS Society, USA
  • 2008
VIEW 2 EXCERPTS

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebocontrolled trial

J Valdez, P Cahn, B Grinsztejn
  • Lancet
  • 2007
VIEW 1 EXCERPT

Update of the drug resistance mutations in HIV-1: Fall 2006.

  • Topics in HIV medicine : a publication of the International AIDS Society, USA
  • 2006